| New Diet Pill Wins FDA Panel's Backing (HealthDay) Posted: 08 Dec 2010 06:03 AM PST HealthDay - TUESDAY, Dec. 7 (HealthDay News) -- An expert advisory panel recommended on Tuesday that Contrave, a new weight-loss pill that combines an antidepressant with an anti-addiction medication, be approved by the U.S. Food and Drug Administration. |
| Study links receipts, cash to cancer and obesity (AFP) Posted: 08 Dec 2010 12:59 AM PST  AFP - Cash register receipts and paper money have been found to contain high levels of bisphenol A (BPA), a chemical linked to cancer, obesity and early puberty, a study published Wednesday says.
|
| FDA panel recommends approval for Contrave (AP) Posted: 07 Dec 2010 09:28 PM PST AP - A Food and Drug Administration panel on Tuesday recommended that the agency approve Orexigen Therapeutics Inc.'s weight loss drug Contrave, making it the first in group of competitors to get a positive nod from experts. |
| Co-Opting Technology for the Sake of Weight Loss (HealthDay) Posted: 07 Dec 2010 08:47 PM PST HealthDay - TUESDAY, Dec. 7 (HealthDay News) -- Might technologies and gadgets so popular with today's young adults be corralled to help them lose weight? |
| U.S. advisers back first new diet pill in a decade (Reuters) Posted: 07 Dec 2010 05:14 PM PST Reuters - The first new weight-loss pill in a decade moved closer to U.S. approval on Tuesday, when a panel of expert advisers backed Orexigen Therapeutics's Contrave despite heart risk concerns. |
| US panel approves first obesity drug in a decade (AFP) Posted: 07 Dec 2010 04:09 PM PST  AFP - An advisory panel to the US Food and Drug Administration on Tuesday gave its approval to an anti-obesity drug, in what could be the first new approved drug for losing weight in more than a decade.
|
| More than half of European adults overweight: study (AFP) Posted: 07 Dec 2010 10:25 AM PST  AFP - More than half of European adults are now overweight and too many children smoke or are obese, raising the risk of cancer or heart attacks, a European health report showed Tuesday.
|
